£520.00

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States

Price data last checked 87 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 4 days • 4 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 26 January 2026 27 January 2026 28 January 2026 29 January 2026

Price Distribution

Price distribution over 4 days • 1 price levels

Days at Price
4 days 0 1 2 3 4 £520 Days at Price

Price Analysis

Most common price: £520 (4 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 4 days

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
98% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Atopic Dermatitis Drugs in the United States
97% match

The 2023-2028 Outlook for Atopic Dermatitis Drugs in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States
97% match

The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Atopic Dermatitis Corticosteroid Drugs in the United States
97% match

The 2023-2028 Outlook for Atopic Dermatitis Corticosteroid Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
97% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Antifungal Drugs in the United States
97% match

The 2023-2028 Outlook for Antifungal Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Schizophrenia Drugs in the United States
97% match

The 2023-2028 Outlook for Schizophrenia Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Topical Antiseptic Medications in the United States
97% match

The 2023-2028 Outlook for Topical Antiseptic Medications in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Malarial Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for OTC Drugs in the United States
97% match

The 2023-2028 Outlook for OTC Drugs in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
97% match

The 2023-2028 Outlook for Erythropoietin Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Atopic Dermatitis Treatments in the United States
97% match

The 2023-2028 Outlook for Atopic Dermatitis Treatments in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Over the Counter Drugs in the United States
97% match

The 2023-2028 Outlook for Over the Counter Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States
97% match

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States
97% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
97% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Anticoagulant Drugs in the United States
97% match

The 2023-2028 Outlook for Anticoagulant Drugs in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Antifungal Azole Drugs in the United States
97% match

The 2023-2028 Outlook for Antifungal Azole Drugs in the United States

£520.00 14 Feb 2026
The 2023-2028 Outlook for Diabetes Drugs in the United States
97% match

The 2023-2028 Outlook for Diabetes Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Hydroxychloroquine Sulphates in the United States
97% match

The 2023-2028 Outlook for Hydroxychloroquine Sulphates in the United States

£520.00 05 Feb 2026